Open AccessRadioembolization of Intrahepatic Cholangiocarcinoma: Patient Selection, Outcomes, and Competing Therapies
Author(s) -
J. Ness,
Christopher Molvar
Publication year - 2021
Publication title -
seminars in interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 40
eISSN - 1098-8963
pISSN - 0739-9529
DOI - 10.1055/s-0041-1735526
Subject(s) - medicine , intrahepatic cholangiocarcinoma , malignancy , stage (stratigraphy) , radiology , overall survival , surgery , paleontology , biology
Intrahepatic cholangiocarcinoma is the second most common primary hepatic malignancy and poses a therapeutic challenge owing to its late-stage presentation and treatment-resistant outcomes. Most patients are diagnosed with locally advanced, unresectable disease and are treated with a combination of systemic and local regional therapies. Transarterial radioembolization offers a survival benefit and a favorable side effect profile, with a growing body of evidence to support its use. Herein, we review patient selection and detail outcomes of radioembolization for intrahepatic cholangiocarcinoma, together with mention of competing treatments.